Efficacy, Acceptability, and Tolerability of Trazodone in Insomnia Symptoms: A Systematic Review and Dose–Response Meta-Analysis
Clinical Drug Investigation · 12.11.2026
DOI: 10.1007/s40261-026-01607-2 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Clinical Drug Investigation, online erschienen am 12.11.2026. Verfasst von Xin Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Sleep Medicine Center, Mental Health Center, National Center for Mental Disorders, Sleep Research Laboratory, West China Hospital, Sichuan University…. Die Arbeit nennt 40 Literaturangaben. Gefördert von: Ministry of Science and Technology of the People's Republic of China, Ministry of Science and Technology of the People’s Republic of China.
Themen: Schlaf
Abstract (Originalsprache)
BACKGROUND AND OBJECTIVE: Trazodone is widely prescribed off label for insomnia symptoms, but the dose range that best balances efficacy with acceptability and tolerability remains uncertain. This systematic review and dose-response meta-analysis evaluated trazodone for insomnia symptoms, with emphasis on clinically relevant dose selection. METHODS: We searched Embase, PubMed, Web of Science, and the Cochrane Library from inception to 17 November 2025, for randomized controlled trials comparing trazodone with placebo or different trazodone doses in patients with insomnia symptoms. Dose-response relationships were evaluated using a one-stage random-effects model with restricted cubic splines. The primary outcome was subjective sleep quality; secondary outcomes were all-cause dropout rate and dropout due to adverse events. RESULTS: Thirteen randomized controlled trials involving 1366 participants were included. Compared with placebo, trazodone moderately improved subjective sleep quality (Cohen's d = 0.67, 95% confidence interval [CI] 0.36-0.98; I2 = 80.86%; p < 0.01). The dose-response curve suggested that efficacy increased at lower doses and approached a plateau around 50 mg/day, although estimates in the higher-dose range were sparse and imprecise. The estimated 50% effective dose was 15.2 mg/day, and the 95% effective dose was 38.2 mg/day, but these estimates should be interpreted as exploratory rather than as precise dose targets. Conventional meta-analysis showed no clear difference in all-cause discontinuation or discontinuation due to adverse events, whereas dose-response analysis suggested a possible dose-related increase in adverse event-related discontinuation. CONCLUSIONS: Trazodone was associated with short-term improvement in subjective sleep quality among heterogeneous populations with insomnia symptoms. The most observable benefit appears to occur at relatively low doses, while dose escalation may offer limited additional benefit and reduce tolerability. However, interpretation of the findings is limited by considerable clinical heterogeneity, sparse evidence at higher doses, and insufficient data on long-term efficacy and safety. PROSPERO REGISTRATION: CRD420251232065.
Autor:innen und Institutionen
- Sleep Medicine Center, Mental Health Center, National Center for Mental Disorders, Sleep Research Laboratory, West China Hospital, Sichuan University, No. 28, Dian Xin Nan Jie, Chengdu, 610041, China.
- Mental Health Center, National Center for Mental Disorders, West China Hospital, Sichuan University, Chengdu, China.
- Sleep Medicine Center, Mental Health Center, National Center for Mental Disorders, Sleep Research Laboratory, West China Hospital, Sichuan University, No. 28, Dian Xin Nan Jie, Chengdu, 610041, China. 2372564613@qq.com.
Förderung
- Ministry of Science and Technology of the People's Republic of China
- Ministry of Science and Technology of the People’s Republic of China
Zitieren
APA
Yang, X., Fang, S., Sun, L., Xiao, B., Lyu, W., Shi, Y., Ren, R., Zhang, Y., Kuang, W., & Tang, X. (2026). Efficacy, Acceptability, and Tolerability of Trazodone in Insomnia Symptoms: A Systematic Review and Dose–Response Meta-Analysis. Clinical Drug Investigation. https://doi.org/10.1007/s40261-026-01607-2
Vancouver
Yang X, Fang S, Sun L, Xiao B, Lyu W, Shi Y, et al. Efficacy, Acceptability, and Tolerability of Trazodone in Insomnia Symptoms: A Systematic Review and Dose–Response Meta-Analysis. Clinical Drug Investigation. 2026. doi:10.1007/s40261-026-01607-2
BibTeX
@article{Yang2026,
author = {Yang, Xin and Fang, Shuping and Sun, Lingqi and Xiao, Bingxue and Lyu, Wenqi and Shi, Yuan and Ren, Rong and Zhang, Ye and Kuang, Weihong and Tang, Xiangdong},
title = {Efficacy, Acceptability, and Tolerability of Trazodone in Insomnia Symptoms: A Systematic Review and Dose–Response Meta-Analysis},
journal = {Clinical Drug Investigation},
year = {2026},
doi = {10.1007/s40261-026-01607-2}
}
EUVIMED